BriaCell $BCTX will present new preclinical data on its Bria-OTS+ cancer vaccine platform at the SITC 40th Anniversary Annual Meeting (Nov 7-9). Investors should watch for insights on how Bria-OTS+ Overcomes Immune Resistance. Full PR here:
https://globenewswire.com/news-release/2025/1...eting.html